<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-2.anc" start="24050" end="24054" sStart="23719" offset="331" sid="r7.1.use.v.0121" wn="1" wnkey="use%2:34:01::" annotator="veweser" text="To test whether the fibulin-1C interaction with proHB-EGF maps to the heparin-binding region, a construct, pGBT9/prodelHB-EGF, containing amino acid residues Asp 106-His 159(the entire EGF like region of proHB-EGF and 18 out of 32 residues of the heparin-binding region) [ 2 ] was used in the yeast two-hybrid system (see materials and methods)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-2.anc" start="4696" end="4700" sStart="null" offset="212" sid="r11.true.j.0542" wn="1" wnkey="true%3:00:00::" annotator="anfahmy" text="The elimination of these false positive colonies from the initial screening of the cDNA library resulted in a total of 64 colonies whose library clones encoded potentially true interacting proteins with the extracellular domain of proHB-EGF." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-2.anc" start="15949" end="15958" sStart="null" offset="280" sid="r8.suggest.v.0267" wn="3" wnkey="suggest%2:32:02::" annotator="brubin" text="These are reasonable functions for the role of the proposed mHB-EGF :LTBP-3 protein:protein interactions as the expression of both mHB-EGF and TGF-? is important during extracellular matrix formation in wound healing [ 1 25 ] ; it has been suggested that the coordinated activities of HB-EGF and TGF-? regulate the wound healing process [ 16 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-2.anc" start="25697" end="25702" sStart="null" offset="30" sid="r9.paper.n.0708" wn="5" wnkey="paper%1:10:02::" annotator="brubin" text="The results presented in this paper now suggest that there is potential in carrying out experiments to further delineate the molecular interactions between proHB-EGF and LTBP-3 and between proHB-EGF and fibulin-1C." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-2.anc" start="17183" end="17189" sStart="null" offset="887" sid="r8.number.n.0421" wn="8" wnkey="number%1:10:02::" annotator="veweser" text="Fibulin-1 is a calcium-binding extracellular matrix glycoprotein that is associated with various connective tissues, basement membranes and blood [ 37 38 39 ] . Splicing of the C terminal domain of fibulin-1 can lead to the expression of different variants of fibulin-1 (A-D) [ 37 ] . The amino acid sequence of the human fibulin-1C protein encodes five domains: a signal sequence (35 amino acid residues), three anaphylatoxin type I repeats (108 residues), an adjoining sequence (33 amino acid residues), nine calcium-binding type II EGF-like modules (387 amino acid residues), and a carboxyl domain (116 amino acid residues) [ 37 ] . The amino acid sequence derived from the nucleotide sequence obtained for monkey fibulin-1C (GenBank accession number AF395659) shows it to share 97." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-2.anc" start="8376" end="8382" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" annotator="veweser" text="It was also surprising that the extracellular portion of any of the EGF receptor proteins was also not represented among the proteins found to interact with the extracellular domain of proHB-EGF, since the &lt;b&gt;mature&lt;/b&gt; protein proteolytically cleaved from proHB-EGF (mHB-EGF) as well as the membrane bound form are known to interact with the EGF receptor." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-2.anc" start="8376" end="8382" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" annotator="jeneale" text="It was also surprising that the extracellular portion of any of the EGF receptor proteins was also not represented among the proteins found to interact with the extracellular domain of proHB-EGF, since the &lt;b&gt;mature&lt;/b&gt; protein proteolytically cleaved from proHB-EGF (mHB-EGF) as well as the membrane bound form are known to interact with the EGF receptor." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-2.anc" start="1003" end="1009" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" annotator="cgozo" text="The precursor of heparin-binding EGF-like growth factor (proHB-EGF) is found on a wide variety of cell surfaces and is present in numerous tissue types [ 1 ] . Previously in our laboratory, we cloned the cDNA encoding proHB-EGF from monkey Vero cells and identified this cell-surface molecule as a receptor for diphtheria toxin (DT) [ 2 ] . The predicted amino acid sequence was shown to be identical to that of the cell surface-expressed precursor of human heparin-binding EGF-like growth factor (proHB-EGF) [ 3 4 ] . The derived amino acid sequence revealed a signal sequence (residues 1-23), an extracellular domain (residues 24-159), a transmembrane domain (residues 160-184), and a carboxyl terminal cytoplasmic domain (residues 185-208) [ 2 ] . Proteolytic processing of the proHB-EGF occurs on the cell surface and results in the release of &lt;b&gt;mature&lt;/b&gt; HB-EGF (mHB-EGF) (residues 63-148) [ 5 ] . The &lt;b&gt;mature&lt;/b&gt;/soluble HB-EGF is a member of the EGF family of growth factors that includes amphiregulin, epidermal growth factor, and transforming growth factor a [ 6 ] . Mature HB-EGF released from the cell surface is mitogenic and is able to bind to the EGF receptor [ 3 ] . Membrane-bound proHB-EGF has juxtacrine growth factor activity [ 7 ] and also acts as a DT receptor [ 2 8 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-2.anc" start="8376" end="8382" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" annotator="cgozo" text="It was also surprising that the extracellular portion of any of the EGF receptor proteins was also not represented among the proteins found to interact with the extracellular domain of proHB-EGF, since the &lt;b&gt;mature&lt;/b&gt; protein proteolytically cleaved from proHB-EGF (mHB-EGF) as well as the membrane bound form are known to interact with the EGF receptor." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-2.anc" start="1065" end="1071" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" annotator="cgozo" text="The precursor of heparin-binding EGF-like growth factor (proHB-EGF) is found on a wide variety of cell surfaces and is present in numerous tissue types [ 1 ] . Previously in our laboratory, we cloned the cDNA encoding proHB-EGF from monkey Vero cells and identified this cell-surface molecule as a receptor for diphtheria toxin (DT) [ 2 ] . The predicted amino acid sequence was shown to be identical to that of the cell surface-expressed precursor of human heparin-binding EGF-like growth factor (proHB-EGF) [ 3 4 ] . The derived amino acid sequence revealed a signal sequence (residues 1-23), an extracellular domain (residues 24-159), a transmembrane domain (residues 160-184), and a carboxyl terminal cytoplasmic domain (residues 185-208) [ 2 ] . Proteolytic processing of the proHB-EGF occurs on the cell surface and results in the release of &lt;b&gt;mature&lt;/b&gt; HB-EGF (mHB-EGF) (residues 63-148) [ 5 ] . The &lt;b&gt;mature&lt;/b&gt;/soluble HB-EGF is a member of the EGF family of growth factors that includes amphiregulin, epidermal growth factor, and transforming growth factor a [ 6 ] . Mature HB-EGF released from the cell surface is mitogenic and is able to bind to the EGF receptor [ 3 ] . Membrane-bound proHB-EGF has juxtacrine growth factor activity [ 7 ] and also acts as a DT receptor [ 2 8 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-2.anc" start="13473" end="13479" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" annotator="cgozo" text="During cellular synthesis of TGF-?, a small latent complex containing the latency-associated peptide and the &lt;b&gt;mature&lt;/b&gt; TGF-? is synthesized." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-2.anc" start="1003" end="1009" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" annotator="brubin" text="The precursor of heparin-binding EGF-like growth factor (proHB-EGF) is found on a wide variety of cell surfaces and is present in numerous tissue types [ 1 ] . Previously in our laboratory, we cloned the cDNA encoding proHB-EGF from monkey Vero cells and identified this cell-surface molecule as a receptor for diphtheria toxin (DT) [ 2 ] . The predicted amino acid sequence was shown to be identical to that of the cell surface-expressed precursor of human heparin-binding EGF-like growth factor (proHB-EGF) [ 3 4 ] . The derived amino acid sequence revealed a signal sequence (residues 1-23), an extracellular domain (residues 24-159), a transmembrane domain (residues 160-184), and a carboxyl terminal cytoplasmic domain (residues 185-208) [ 2 ] . Proteolytic processing of the proHB-EGF occurs on the cell surface and results in the release of &lt;b&gt;mature&lt;/b&gt; HB-EGF (mHB-EGF) (residues 63-148) [ 5 ] . The &lt;b&gt;mature&lt;/b&gt;/soluble HB-EGF is a member of the EGF family of growth factors that includes amphiregulin, epidermal growth factor, and transforming growth factor a [ 6 ] . Mature HB-EGF released from the cell surface is mitogenic and is able to bind to the EGF receptor [ 3 ] . Membrane-bound proHB-EGF has juxtacrine growth factor activity [ 7 ] and also acts as a DT receptor [ 2 8 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-2.anc" start="8376" end="8382" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" annotator="brubin" text="It was also surprising that the extracellular portion of any of the EGF receptor proteins was also not represented among the proteins found to interact with the extracellular domain of proHB-EGF, since the &lt;b&gt;mature&lt;/b&gt; protein proteolytically cleaved from proHB-EGF (mHB-EGF) as well as the membrane bound form are known to interact with the EGF receptor." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-2.anc" start="1065" end="1071" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" annotator="brubin" text="The precursor of heparin-binding EGF-like growth factor (proHB-EGF) is found on a wide variety of cell surfaces and is present in numerous tissue types [ 1 ] . Previously in our laboratory, we cloned the cDNA encoding proHB-EGF from monkey Vero cells and identified this cell-surface molecule as a receptor for diphtheria toxin (DT) [ 2 ] . The predicted amino acid sequence was shown to be identical to that of the cell surface-expressed precursor of human heparin-binding EGF-like growth factor (proHB-EGF) [ 3 4 ] . The derived amino acid sequence revealed a signal sequence (residues 1-23), an extracellular domain (residues 24-159), a transmembrane domain (residues 160-184), and a carboxyl terminal cytoplasmic domain (residues 185-208) [ 2 ] . Proteolytic processing of the proHB-EGF occurs on the cell surface and results in the release of &lt;b&gt;mature&lt;/b&gt; HB-EGF (mHB-EGF) (residues 63-148) [ 5 ] . The &lt;b&gt;mature&lt;/b&gt;/soluble HB-EGF is a member of the EGF family of growth factors that includes amphiregulin, epidermal growth factor, and transforming growth factor a [ 6 ] . Mature HB-EGF released from the cell surface is mitogenic and is able to bind to the EGF receptor [ 3 ] . Membrane-bound proHB-EGF has juxtacrine growth factor activity [ 7 ] and also acts as a DT receptor [ 2 8 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-2.anc" start="13473" end="13479" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" annotator="brubin" text="During cellular synthesis of TGF-?, a small latent complex containing the latency-associated peptide and the &lt;b&gt;mature&lt;/b&gt; TGF-? is synthesized." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-2.anc" start="8846" end="8851" sStart="null" offset="181" sid="r8.1.great.j.0025" wn="1" wnkey="great%5:00:01:large:00" annotator="veweser" text="The positive interaction of the fragment of the latent transforming growth factor ?-binding protein-3 (LTBP-3) with the extracellular domain of proHB-EGF was of great interest (Additional file 1)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-2.anc" start="8846" end="8851" sStart="null" offset="181" sid="r8.1.great.j.0025" wn="1" wnkey="great%5:00:01:large:00" annotator="jeneale" text="The positive interaction of the fragment of the latent transforming growth factor ?-binding protein-3 (LTBP-3) with the extracellular domain of proHB-EGF was of great interest (Additional file 1)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-2.anc" start="8846" end="8851" sStart="null" offset="181" sid="r8.1.great.j.0025" wn="1" wnkey="great%5:00:01:large:00" annotator="cgozo" text="The positive interaction of the fragment of the latent transforming growth factor ?-binding protein-3 (LTBP-3) with the extracellular domain of proHB-EGF was of great interest (Additional file 1)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-2.anc" start="8846" end="8851" sStart="null" offset="181" sid="r8.1.great.j.0025" wn="1" wnkey="great%5:00:01:large:00" annotator="brubin" text="The positive interaction of the fragment of the latent transforming growth factor ?-binding protein-3 (LTBP-3) with the extracellular domain of proHB-EGF was of great interest (Additional file 1)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-2.anc" start="27584" end="27593" sStart="null" offset="119" sid="r11.function.n.0754" wn="2" wnkey="function%1:07:00::" annotator="vebatchelder" text="Therefore, the interactions of HB-EGF with LTBP-3 and fibulin-1C described in this study suggest novel functions for HB-EGF between cell-surfaces and tissue surfaces." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-2.anc" start="16584" end="16593" sStart="null" offset="288" sid="r8.1.different.j.0872" wn="1" wnkey="different%3:00:00::" annotator="cgozo" text="Fibulin-1 is a calcium-binding extracellular matrix glycoprotein that is associated with various connective tissues, basement membranes and blood [ 37 38 39 ] . Splicing of the C terminal domain of fibulin-1 can lead to the expression of different variants of fibulin-1 (A-D) [ 37 ] . The amino acid sequence of the human fibulin-1C protein encodes five domains: a signal sequence (35 amino acid residues), three anaphylatoxin type I repeats (108 residues), an adjoining sequence (33 amino acid residues), nine calcium-binding type II EGF-like modules (387 amino acid residues), and a carboxyl domain (116 amino acid residues) [ 37 ] . The amino acid sequence derived from the nucleotide sequence obtained for monkey fibulin-1C (GenBank accession number AF395659) shows it to share 97." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-2.anc" start="29926" end="29933" sStart="null" offset="11" sid="r10.control.n.0939" wn="4" wnkey="control%1:09:02::" annotator="cgozo" text="A positive control of Y187 or Y190 containing both plasmids pTD1 and pVA3 together was included in every ?-galactosidase assay." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-2.anc" start="11573" end="11584" sStart="null" offset="37" sid="r11.combination.n.0180" wn="1" wnkey="combination%1:14:00::" annotator="adelpriore" text="It is interesting that the combination of colony hybridization and yeast two-hybrid screens used in this study to identify proteins that interact with the extracellular domain of proHB-EGF yielded independent GAL4-LTBP-3 fusion proteins that all contained these calcium-binding type II EGF-like domains (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-2.anc" start="14205" end="14209" sStart="null" offset="703" sid="r11.able.j.0126" wn="3" wnkey="able%5:00:00:capable:00" annotator="adelpriore" text="This small latent complex may be secreted inefficiently from the cell surface at relatively slow rates [ 23 ] . However, when the small latent complex is bound by the latent transforming growth factor ?-binding protein via a disulfide bond to the latency-associated peptide, the result is the formation of a large latent complex which may be secreted efficiently and at a relatively high rate compared to the small latent complex [ 23 ] . Latent TGF-? is then released from the extracellular matrix via proteolytic cleavage from the large latent complex, and the resulting active TGF-? is now able to bind to the appropriate TGF-? cell-surface receptors [ 24 ] ." />
  </sentences>
</list>